AzTrials
AzTrials

Adult WomenNCT07716514

Interoceptive Awareness and Dream Themes

An observational study of Adult Women, run by Recep Tayyip Erdogan University at 1 site in Turkey (Türkiye).

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Individual differences in reported dream themes may reflect not only waking emotional and cognitive experiences but also characteristic ways of attending to, interpreting, and regulating bodily signals. Read more about this study

Who is it for?
Ages 18 to 65 years, women onlyHealthy volunteers can take part
Conditions the study is for
Adult Women
How many people
307 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jul 2026to 10 Aug 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: This cross-sectional observational study examines conditional associations between multidimensional subjective interoceptive awareness and self-reported dream themes in community-dwelling women aged 18-65 years.

Who may be able to join

  • being 18-65 years old
  • being able to understand written Turkish
  • having sufficient cognitive capacity to complete the questionnaires
  • providing written informed consent.

Who cannot join

  • were an active psychotic disorder
  • a severe neurological condition, or cognitive impairment that substantially interfered with questionnaire comprehension.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • RTEU Guneysu FTRYO

    Rize

Other trials in Turkey (Türkiye)

About this study

Official title: Multidimensional Interoceptive Awareness and Dream Themes in Adult Women: Incremental Associations Beyond Alexithymia, Psychological Distress, Sleep Quality, and Somatic Symptoms

Individual differences in reported dream themes may reflect not only waking emotional and cognitive experiences but also characteristic ways of attending to, interpreting, and regulating bodily signals. Associations between interoceptive awareness and dream themes may reflect variance shared with alexithymia, psychological distress, sleep disturbance, and somatic symptoms. This study examined whether six dimensions of subjective interoceptive awareness accounted for incremental variance in dream themes beyond established emotional, sleep-related, and somatic correlates in adult women.

Read the detailed description

Existing studies have primarily examined nightmares, nightmare distress, dream frequency, subjective sleepiness, or general sleep quality. They have not established whether multidimensional self-reported interoceptive awareness accounts for incremental variance in overall reported dream themes after emotional, sleep-related, somatic, and dream recall-related correlates are considered simultaneously. The present study therefore examined whether six dimensions of subjective interoceptive awareness jointly accounted for incremental variance in overall Dream Themes Scale scores among adult women beyond age, dream recall frequency, chronic disease, menopausal status, anxiety, depressive symptoms, alexithymia, subjective sleep quality, and somatic symptom burden. The primary hypothesis was that the six interoceptive-awareness dimensions would jointly account for a small but detectable increment in explained variance after the covariates had been entered.

Conditions
Adult Women
Keywords
Interoceptive awareness, Dream themes, Alexithymia, Psychological distress, Somatic symptoms, Sleep quality
Medical subject headings
Affective Symptoms, Medically Unexplained Symptoms, Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07716514
Study groupRoleWhat they receive
Community-dwelling womenThis cross-sectional observational study examined conditional associations between multidimensional subjective interoceptive awareness and self-reported dream themes in community-dwelling women aged 18-65 years.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Interoceptive Awareness

    Interoceptive awareness was assessed using the Turkish adaptation of the Multidimensional Assessment of Interoceptive Awareness, Version 2. The original MAIA-2 contains 37 items and eight dimensions. In the Turkish validation study, five original items were removed, producing a 32-item, six-factor solution comprising Emotional Awareness, Attention Regulation, Body Listening, Not-Distracting, Trusting, and Not-Worrying. Items are rated from 0 ("never") to 5 ("always"). Each dimension score was calculated as the mean of its constituent items after applying the direction of scoring specified for the administered form. Higher scores indicate a greater level of the tendency represented by the corresponding dimension.

    Measured: At baseline

  2. Dream Themes

    The Dream Themes Scale (DTS) is a 29-item Turkish self-report measure assessing the frequency of themes in recalled dreams. Items are rated from 0 ("never") to 4 ("always"). The total score ranges from 0 to 116, with higher scores indicating more frequent endorsement of the assessed dream themes. The original development study identified five correlated dimensions: Negative Themes, Anxiety Themes, Fear Themes, Effects of Waking-Life Experiences, and Frustration Themes. The DTS total score was prespecified as the primary outcome and was used as a descriptive composite reflecting the overall frequency of endorsed dream themes across five related domains. The five DTS subscales were additionally examined as secondary outcomes to evaluate whether the observed associations were domain-specific.

    Measured: At baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2026
  2. Study start1 Jul 2026
  3. Primary completion1 Aug 2026 (estimated)
  4. Study completion10 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
307 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07716514
Sponsor's protocol ID
2026/136
Status last verified
Jul 2026
First submitted
16 Jul 2026
Last updated
21 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: I do not prefer

Questions about this trial

What is this clinical trial studying?

An observational study of Adult Women, run by Recep Tayyip Erdogan University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 21 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Interoceptive Awareness (time frame: At baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in